CHI and Bio-IT World Announce New Targets and Drug Modalities Session at Upcoming Event

April 19, 2011 - PRLog -- Cambridge Healthtech Institute and Bio-IT World is pleased to announce a new session just added to its 11th Annual Structure-Based Drug Design (SBDD) conference.  The session is titled New Targets and Drug Modalities.  The SBDD conference will be held on June 8-10, 2011 at the Royal Sonesta Hotel Boston in Cambridge, Massachusetts.  This meeting serves as the annual forum for the structure-based drug design community, providing insights on the latest development in computational technology for drug discovery, and puts structure-based molecular approaches into the perspective of targeted therapeutics.

The New Targets and Drug Modalities session is scheduled on Friday, June 10 from 1:30– 3:50 p.m.  The following presentations are scheduled during this time:

Structure-Based Ligand Discovery for GPCRs
Ruben Abagyan, Ph.D., Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Francisco

The Role of Recent Crystal Structures of Membrane Bound Proteins in Drug Discovery for CNS Targets
Sid Topiol, Ph.D., CSO, Computational and Structural Investigations, 3D-2Drug

Hitting a Moving Target: Characterizing GPCR Signaling through Long-timescale Molecular Dynamics Simulations
Ron Dror, Ph.D., Senior Research Scientist and Special Advisor to the Chairman, D. E. Shaw Research

Beyond the Orthosteric Binding Site: A Structure-Based SAR Analysis of the D3R Selective Compounds
Lei Shi, Ph.D., Assistant Professor, Department of Physiology and Biophysics, HRH Prince
Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College

Moving in New Circles – Exploiting Macrocycles for Drug Discovery
Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp

View full details and register at: http://www.healthtech.com/sbd

Those that register by April 29 will receive the advanced registration discount.

Writers and editors are invited to attend.  To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (http://www.chicorporate.com)
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About Bio-IT World: (http://www.bio-itworld.com)
Part of the Cambridge Healthtech Institute Media Group (http://www.chimediagroup.com), Bio-IT World magazine is a bimonthly publication that life science and IT/informatics professionals continuously reference to find information, news, and commentary on indispensable technologies and business strategies.  Bio-IT World provides outstanding coverage of cutting-edge trends and technologies that impact the management and analysis of life sciences data, including next-generation sequencing, drug discovery, predictive and systems biology, informatics tools, clinical trials, and personalized medicine. Cambridge Healthtech Media Group also hosts daily news and opinion at http://www.bio-itworld.com, a variety of e-newsletters, and a rich compendium of webinars and web symposia.  Cambridge Healthtech Media Group is based in Needham, Mass.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com
http://www.healthtech.com/sbd